We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App





Abbott Diagnostics Displays Alinity Family of Systems

By LabMedica International staff writers
Posted on 02 Aug 2018
Print article
Image: The Alinity on display at AACC 2018 (Photo courtesy of Abbott).
Image: The Alinity on display at AACC 2018 (Photo courtesy of Abbott).
Abbott Diagnostics (Abbott Park, IL, USA) displayed the Alinity next-generation family of systems at this year’s AACC Annual Scientific Meeting & Clinical Lab Expo in Chicago, Illinois, USA. The Alinity harmonized family of systems across key laboratory disciplines is designed to simplify diagnostics and help deliver results that drive better patient outcomes.

Abbott's Alinity family of harmonized solutions is unprecedented in the diagnostics industry, working together to address the challenges of using multiple diagnostics platforms and simplify diagnostic testing. Alinity systems are designed to be more efficient – running more tests in less space, generating test results faster and minimizing human errors – while continuing to provide quality results.

The Alinity portfolio includes clinical chemistry, immunoassay, blood and plasma screening, point of care, hematology and molecular diagnostics, along with Abbott's AlinIQ—a first-of-its-kind, holistic suite of professional services that combines expertise with process analysis and informatics.

The Alinity ci-series combines the power of integrated clinical chemistry and immunoassay systems in unprecedented, innovative combinations to meet every laboratory's needs. The Alinity h-series solution integrates the Alinity hq with the Alinity hs slide maker and stainer module into a combined solution for hematology testing. The Alinity h-series solution is 20% faster per m2 than other currently available integrated hematology systems with a throughput of 133 complete blood counts (CBCs) per m2.

The Alinity m molecular system addresses operational complexities, such as increasing the capacity for growth, improving workflow efficiencies and reducing demand on labor. The Alinity s system for blood and plasma screening is designed to screen blood and plasma faster and more efficiently within a smaller footprint, helps blood and plasma centers improve productivity and maintain the highest levels of accuracy, without expanding the instrument footprint.

The Alinity PRO software works with all Alinity systems to fully maximize their potential and enhance operational productivity throughout the network, allowing for easier and consolidated system monitoring anytime, anywhere. And with predictive system monitoring through AlinIQ Always On, Abbott’s professional services can proactively monitor the health of these systems and help avoid unexpected downtime.

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: Comparison of traditional histopathology imaging vs. PARS raw data (Photo courtesy of University of Waterloo)

AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis

The process of biopsy is important for confirming the presence of cancer. In the conventional histopathology technique, tissue is excised, sliced, stained, mounted on slides, and examined under a microscope... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.